&nbsp;

Breast-Screen-saver-and-Slide_French.zip

May 2025

Document

Breast-Screen-saver-and-Slide_Other Languages.zip

May 2025

Document

Breast-Postcard-Other-Languages.zip

May 2025

Regimen

BORTDEXALENA+DARA(SC); LENA+DARA(MNT-SC)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

New Drug Funding Program

Bortezomib - Previously Untreated - Multiple Myeloma Pre-Stem Cell Transplant

ODB - General Benefit

dexamethasone

Drugs Used:

daratumumab (subcut) (Unfunded),

bortezomib (Unfunded),

lenalidomide (Unfunded),

dexamethasone

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

BrECADD

Cancer Type:

Hematologic,

Lymphoma - Hodgkin

Intent: Curative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

brentuximab vedotin (Unfunded),

Quick Link(s):

Regimen Monograph

May 2025

Regimen

BLIN

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative, Palliative

Funding:

New Drug Funding Program

Blinatumomab - Front-line Consolidation for B-cell Precursor Acute Lymphoblastic Leukemia

Drugs Used:

blinatumomab

Quick Link(s):

Regimen Monograph

Dec 2025

Document

Breast-Cancer-Screening-for-People-Ages-40-to-49_Eastern-Ojibway.pdf

May 2025

Document

Breast-Cancer-Screening-for-People-Ages-40-to-49_Moose-Cree.pdf

May 2025

Document

Breast-Cancer-Screening-for-People-Ages-40-to-49_Swampy-Cree.pdf

May 2025

Regimen

NIVL+IPIL

Cancer Type:

Skin,

Melanoma

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

Drugs Used:

nivolumab,

ipilimumab

Quick Link(s):

Regimen Monograph

May 2025

Regimen

NIVL

Cancer Type:

Skin,

Melanoma

Intent: Adjuvant

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - (Neo)adjuvant Resectable Macroscopic Stage III Melanoma

Drugs Used:

nivolumab